The IMMEDIATE (Immediate Metabolic Myocardial Enhancement During Initial Assessment and Treatment in Emergency Care) Trial is a NIH National Heart, Lung, Blood Institute sponsored study that is testing whether giving an Intravenous (IV) solution of readily available medications (Glucose, Insulin and potassium), referred to as “GIK” is helpful to patients at the first signs of a heart attack.

July 31, 2011 was the last day of enrollment into the IMMEDIATE Trial! The leadership and staff from the national Coordinating Center in Boston extend their gratitude to all of the paramedics for their commitment to study and staying strong until the very end. We also thank the nurses and doctors at the receiving hospitals who continued the study drug and ensured compliance with the study protocol. It has been a privilege and honor to work with the paramedics and we truly believe that together we demonstrated that prehospital research can be successful.